Metastases
Conditions
Interventions
Group one:Treated with domestic innovative integrated radiotherapy equipment
Sponsors
Chinese PLA General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1)Patients must provide informed consent for the study voluntarily and possess the capacity for autonomous decision-making, signing the informed consent form within 30 days prior to enrollment; (2)The primary tumor is confirmed by histopathology to be a solid malignant tumor with distant metastasis; (3)Have indications for external beam SRT technology radiotherapy; (4)Necessary assessments and examinations before treatment must be completed prior to enrollment; (5)Willing and able to participate in regular follow-up.
Exclusion criteria
Exclusion criteria: (1)Conventional fractionated radiotherapy is planned; (2)Serious medical conditions that could significantly affect compliance with the clinical trial, such as unstable heart disease, kidney disease, chronic hepatitis, poorly controlled diabetes, and psychiatric disorders, among others; (3)Other situations in which researchers deem the individual unsuitable for participation in this clinical study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Local control rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall Survival;Disease progression free survival; | — |
Countries
China
Contacts
Public ContactDu Lehui
Chinese PLA General Hospital
Outcome results
None listed